The Ubiquitin/SUMO pathway and radial ray deficiency syndromes

Annals of Plastic Surgery

Volumn 70, Issue 2, 2013, Pages 240-245

  Al Qattan, Mohammad M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Radial ray deficiency; SUMO; Ubiquitin

Indexed keywords

SUMO PROTEIN; UBIQUITIN;

CONGENITAL MALFORMATION; GENETICS; GREAT VESSELS TRANSPOSITION; HEART SEPTUM DEFECT; HUMAN; LIMB MALFORMATION; METABOLISM; RADIUS; REVIEW; SYNDROME; THUMB; X CHROMOSOME LINKED DISORDER;

GENETIC DISEASES, X-LINKED; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; LIMB DEFORMITIES, CONGENITAL; RADIUS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SYNDROME; THUMB; TRANSPOSITION OF GREAT VESSELS; UBIQUITIN;

MLCS; MLOWN;

EID: 84872905483     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0b013e318236452b     Document Type: Review

References (63)

1. Bergink S, Jentsch S. Principle of ubiquitin and SUMO modifications in DNA repair. Nature. 2009;458: 461-467.
2. Lindor NM, Furucichi Y, Kitao S, et al. Rothmund-Thomson syndrome due to RECQ4 Helicase mutations: report and clinical and molecular comparisons with Bloom syndrome and Werner syndrome. Am J Med Genet. 2000;90: 223-228.
3. Siitonen HA, Sotkasiira J, Biervliet M, et al. The mutation spectrum in RECQL4 diseases. Eur J Hum Genet. 2009;17: 151-158.
4. Van Maldergem L, Siitonen HA, Jalkh N, et al. Revisiting the craniosynostosisradial ray hypoplasia association: Baller-Gerold syndrome caused by mutation in the RECQL4 gene. J Med Genet. 2006;43: 148-152.
5. Wang LL, levy ML, Lewis RA, et al. Clinical manifestations in cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Gene. 2001; 102: 11-17.
6. Yin J, Kwon YT, Varsharsky A, et al. RECQL4, mutated in the Rothmund- Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. Hum Mol Genet. 2004; 13: 2421-2430.
7. Derradji H, Bekaert S, De Meyer T, et al. Ionizing radiation induced gene modulations, cytokine content changes and telomere shortening in mouse fetuses exhibiting forelimb defects. Dev Biol. 2008;322: 302-313.
8. Ozdemir OM, Kilic I, Ozsari T, et al. Fetal sodium valproate exposure causes Baller-Gerold Syndrome phenotype: both phenotypes in the same family. Turk J Pediatr. 2009;51: 631-636.
9. Chen J, Halappanavar S, Th'ng JPH, et al. Ubiquitin-dependent distribution of the transcriptional coactivator p300 in cytoplasmic inclusion bodies. Epigenetics. 2007;2: 92-103.
10. Kramer OH, Zhu P, Ostendorff HP, et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 2003;22: 3411-3420.
11. D'Andrea. Susceptibility pathways in Fanconi's anemia and breast cancer. N Eng J Med. 2010;362: 1909-1919.
12. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fancani anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7: 249-262.
13. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nature Genet. 2003;35: 165-170.
14. Smogorzewska A, Matsuoka S, Vinciguerra P, et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129: 289-301.
15. Titus TA, Yan YL,Wilson C, et al. The Fanconi anemia/BRCA gene network in zebrafish: embryonic expression and comparative genomics. Mutat Res. 2009;31: 117-132.
16. Botto LD, Khouny MJ, Mastrociacoro P, et al. The spectrum of congenital anomalies of VATER association: an international study. Am J Med Genet. 1997;71: 8-15.
17. Solomon BD, Pineda-Alvarez DE, Roam MS, et al. Evidence for inheritance in patients with VACTERL association. Hum Genet. 2010;127: 731-733.
18. Schramm C, Draaken M, Burtels E, et al. De novo microduplication at 22q11.21 in a patient with VACTERL association. Eur J Med Genet. 2011;54: 9-13.
19. Arrington CB, Patel A, Bacino CA, et al. Haploinsufficiency of the LIM domain containing preferred translocation partner in lipoma (LPP) gene in patients with tetralogy of Fallot and VACTERL association. Am J Med Genet A. 2010;152: 2919-2923.
20. Holden ST, Cox JJ, Kesterton I, et al. Fanconi anemia complementation group B presenting as X-linked VACTERL with hydrocephalus syndrome. J Med Genet. 2006;43: 750-754.
21. Lomas FE, Dahlstrom JE, Ford JH. VACTREL with hydrocephalus: family with X-linked VACTERL-H. Am J Med Genet. 1998;76: 74-78.
22. Meetei AR, Levitus M, Xue Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet. 2004;36: 1219-1224.
23. Celli J, Van Bekhoven H, Brunner HG. Feingold syndrome: clinical review and genetic mapping. Am J Med Genet A. 2003;122: 294-300.
24. Ota S, Zhou ZQ, Keene DR, et al. Activities of N-Myc in the developing limb link central of skeletal size with digit separation. Development. 2007;134: 1583-1592.
25. Zhao X, D'Arca D, Lim WK, et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev Cell. 2009;17: 210-221.
26. Edison RJ, Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet A. 2004;15: 287-298.
27. De Graaff E, Kozin SH. Genetics of radial deficiencies. J Bone Joint Surg Am. 2009;91(suppl 4): 81-86.
28. Paajarvi G, Randier E, Crisby M, et al. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. FASEB J. 2005;19: 476-478.
29. Doolman R, Leichner GS, Avner R, et al. Ubiquitin is conjugated by membrane ubiquitin ligase to three sites, including the N terminus, in transmembrane region of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase. Implications for sterol-regulated enzyme degradation. J Biol Chem. 2000;275: 35840-35847.
30. Diez-Pardo JA, Baoquan Q, Navarro C, et al. A new rodent experimental model of esophageal atresia and tracheo-esophageal fistula: preliminary report. J Pediatr Surg. 1996;31: 498-502.
31. Liu J, Zheng H, Tang M, et al. A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting both the ubiquitination apparatus and proteasome. Am J Physiol Heart Circ Physiol. 2008;295: 2541-2550.
32. Morimoto T, Fukita M, Kawamura T, et al. Myocardial regulation of p300 and p53 by doxorubicin involves ubiquitin pathways. Cir J. 2008;72: 1506-1511.
33. Botzenhart EM, Bartaini G, Blair E, et al. Townes-Brocks Syndrome: twenty novel SALL1 mutations in sporadic and familial cases and refinement of the SALL1 hotspot region. Hum Mutat. 2007;28: 204-205.
34. Kohlhase J, Heinrich M, Schubert L, et al. Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet. 2002;11: 2979-2987.
35. Kohlhase J, Wischermann A, Reichenbach H, et al. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks Syndrome. Nat Genet. 1998;18: 81-83.
36. Koshiba-Takenchi K, Takenchi JK, Arruda EP, et al. Cooperation and antagonistic interactions between SALL4 and TBX5 pattern the mouse limbs and heart. Nat Genet. 2006;38: 175-183.
37. Newbury-Ecob RA, Leanage R, Raeburn JA, et al. Holt-Oram syndrome: a clinical genetic study. J Med Genet. 1996;33: 300-307.
38. Kawakami Y, Uchiyama Y, Esteban CR, et al. SALL genes regulate regionspecific morphogenesis in the mouse limb by modulating Hox activities. Development. 2009;136: 585-594.
39. Linhares VL, Almeida NA, Menezes DC, et al. Transcriptional regulation of the murine connexin 40 promoter by cardiac factors Nkx 2.5, GATA4, and Tbx5. Cardiovasc Res. 2004;64: 402-411.
40. Bohm J, Sustmann C, Wilhelm C, et al. SALL4 is directly activated by TCF/ LEF in the canonical Wnt signaling pathway. Biochem Biophys Res Commun. 2006;348: 898-907.
41. Kohlhase J, Schubart L, Liebers M, et al. Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram Syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy. J Med Genet. 2003;40: 473-478.
42. Sakaki-Yumoto M, Kobayashi C, Sato A, et al. The murine homolog of SALL4, a causative gene in Okihiro Syndrome, is essential for embryonic stem cell proliferation and cooperates with SALL1 in anorectal, heart, brain, and kidney development. Development. 2006;133: 3005-3013.
43. Sato A, Kishida S, Tanaka T, et al. SALL1, a causative gene for Townes-Brocks Syndrome, enhances the canonical Wnt signaling by localizing to heterochromatin. Biochem Biophys Res Commun. 2004;319: 103-113.
44. De Celis JF, Barrio R. Regulation and function of spalt proteins during animal development. Dev Biol. 2009;53: 1385-1398.
45. Netzer C, Bohlander SK, Rieger L, et al. Interaction of the developmental regulator SALL1 with UBE21 and SUMO-1. Biochem Biophys Res Comm. 2002;296: 870-876.
46. Sanchez J, Talamillo A, Lopitz-Otsoa F, et al. SUMOylation modulates the activity of spalt like proteins during wing development in Drosophila. J Biol Chem. 2010;285: 25841-25849.
47. Schule B, Oviedo A, Johnston K, et al. Inactivating mutations in ESCO2 cause SC phocomelia and Roberts Syndrome: no phenotype-genotype correlation. Am J Hum Genet. 2005;77: 1117-1128.
48. Goh ES, Li C, Horsburgh S, et al. The Roberts syndrome/SC phocomelia spectrum: a case report of an adult with review of literature. Am J Med Genet (Part A). 2010;152: 472-478.
49. Vega H, Trainer AH, Gordillo M, et al. Phenotypic variability in 49 cases of ESCO2 mutations including novel missense and codon deletion in the acetyltransferase domain, correlates with ESCO2 expression and establishes the clinical criteria for Roberts syndrome. J Med Genet. 2010;47: 30-37.
50. Gordillo M, Vega H, Trainer AH, et al. The molecular mechanism underlying Roberts syndrome involves loss of ESCO2 acetyltransferase activity. Hum Mol Genet. 2008;17: 2172-2180.
51. Van der Lelij P, Godthelp BC, Van Zou W, et al. The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2. Plos One. 2009;4:e6936.
52. Bachant J, Alcasabas A, Blat Y, et al. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol Cell. 2002;9: 1169-1182.
53. Agostinho M, Santros V, Ferreira F, et al. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity. Cancer Res. 2008;68: 2409-2418.
54. Ito T, Ando H, Suzuki T, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327: 1345-1350.
55. Hall JG. Thrombocytopenia and absent radius (TAR) syndrome. J Med Genet. 1987;24: 79-83.
56. Goldfarb CA, Wustrack R, Pratt JA, et al. Thumb function and appearance in thrombocytopenia absent radius syndrome. J Hand Surg Am. 2007;32: 157-161.
57. Klopocki E, Shulz H, Straub G, et al. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopeniaabsent radius syndrome. Am J Hum Genet. 2007;80: 232-240.
58. Wang B, Fujita K, Ohhira C, et al. Radiation-induced apoptosis and limb teratogenesis in embryonic mice. Radiat Res. 1999;151: 63-68.
59. Talamillo A, Sanchez J, Barrio R. Functional analysis of the SUMOylation pathway in Drosophila. Biochem Soc Trans. 2008;36: 868-873.
60. Chen M, Tomkins DJ, Averback W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia. Nat Genet. 1996;12: 448-451.
61. Houghtaling S, Timmers C, Noll M, et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 2003;17: 2021-2035.
62. Wong JC, Alon N, McKerlie C, et al. Targeted disruption of exons 1 to 6 of the Fanconi anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum Mol Genet. 2003;12: 2063-2076.
63. Kim J, Kim P, Hui CC. The VACTERL association: lessons from the sonic hedgehog pathway. Clin Genet. 2001;59: 306-315.